AI assistant
Sending…
Oramed Pharmaceuticals Inc. — Director's Dealing 2015
Dec 9, 2015
6965_dirs_2015-12-09_02f522b7-357f-4972-8791-0fd86498dba8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2015-12-07
Reporting Person: Berelowitz Michael (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-07 | Common Stock | S | 539 | $8.70 | Disposed | 24357 | Direct |
| 2015-12-08 | Common Stock | S | 761 | $8.70 | Disposed | 23596 | Direct |
More from Oramed Pharmaceuticals Inc.
Interim / Quarterly Report
2026
May 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Capital/Financing Update
2026
Feb 20
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Jan 29
Major Shareholding Notification
2026
Jan 29
Director's Dealing
2026
Jan 29